Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

What to Expect in State Legislatures in 2021

Joseph Cantrell, JD  |  Issue: March 2021  |  January 25, 2021

Other Issues
We do expect to see some movement on our other issues, such as drug pricing transparency, prior authorization and non-medical switching. However, we expect to see significantly fewer bills on prior authorization and non-medical switching than on the three main issues described above. There will be many pieces of legislation addressing drug price transparency, but we are not expecting to see many sweeping pharmacy benefit manager reform measures like those we have seen in the past. The bills that have been introduced so far are narrow in scope but much more viable in the current environment than larger reform packages.

How You Can Help
Finally, it is important to address the proverbial elephant in the room. COVID-19 has dramatically changed the way that we interact with legislators. The primary challenge that we will face as an advocacy community in 2021 is developing strategies to effectively advocate when we cannot advocate in person. This year, your participation and use of digital platforms are more important than ever to help ensure advocacy wins. Visit the ACR’s Legislative Action Center and complete the federal and state alerts throughout the year. The voices and support of our members have always been what makes our advocacy wins possible. During this public health emergency and worldwide pandemic, we need those voices to be louder than ever before.  You can also contact the ACR’s advocacy team for help with issues you are experiencing in your area or practice by emailing [email protected].

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Joseph Cantrell, JD, is the senior manager of state affairs for the ACR.

Page: 1 2 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:copay accumulatorsLegislation & Advocacystep therapy reform legislationtelemedicine

Related Articles

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

    felipe caparros / shutterstock.com

    Copay Accumulator Programs Can Derail Rheumatologic Treatment Plans

    February 13, 2020

    As the medications for rheumatology become more expensive, the need for patient financial assistance becomes paramount. Unfortunately, commercially insured patients are finding it difficult to afford the exorbitant copays required by their plans, and the latest strategy of pharmacy benefit managers (PBMs) threatens to derail rheumatologic treatment goals. High deductible plans combined with copay accumulator…

    What to Expect in Healthcare Policy from the 2023 State Legislative Sessions

    February 21, 2023

    With 2023 state legislative sessions underway, early prevailing themes may forecast areas where we will see gains this year. Key issues include utilization management, copay accumulator bans, white bagging and pharmacy benefit manager reform.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences